T Cells Predict Outcome in Zoledronate-Treated Breast Cancer Patients

Oncologist - United States
doi 10.1634/theoncologist.2013-0097
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

E-Cadherin Genetic Variants Predict Survival Outcome in Breast Cancer Patients

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

More T Cells Versus Better T Cells in Patients With Breast Cancer

Cancer Discovery
Oncology
2017English

Enhancing Adoptive Cancer Immunotherapy With Vγ2Vδ2 T Cells Through Pulse Zoledronate Stimulation

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer

Cancer Research
Cancer ResearchOncology
2016English

Baseline Circulating Stem-Like Cells Predict Survival in Patients With Metastatic Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

TSC22D1 and PSAP Predict Clinical Outcome of Tamoxifen Treatment in Patients With Recurrent Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

CD4+ and CD8+ T Cells Have Opposing Roles in Breast Cancer Progression and Outcome

Oncotarget
Oncology
2015English

Comprehensive CYP2D6 Genotype and Adherence Affect Outcome in Breast Cancer Patients Treated With Tamoxifen Monotherapy

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Resident Memory CD8+ T Cells Within Cancer Islands Mediate Survival in Breast Cancer Patients

JCI insight
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy